What is the current Price Target for the ProPhase Labs, Inc. stock?

The average ProPhase Labs, Inc. target price is $16.00. This is 4,524.28% higher than the current stock price. 1 Analyst has issued a ProPhase Labs, Inc. price target 2026.

How high will the ProPhase Labs, Inc. stock rise?

No reliable answer can be given as to how high the ProPhase Labs, Inc. stock will rise. The performance of stocks, including the ProPhase Labs, Inc. stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the ProPhase Labs, Inc. stock today?

The performance of ProPhase Labs, Inc. stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the ProPhase Labs, Inc. stock fall?

The decline in ProPhase Labs, Inc. stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

ProPhase Labs, Inc. Forecast, price target & analysts

$0.26

24.19% today

Nasdaq, Apr 04, 09:18 pm CET

ISIN

US74345W1080

Symbol

PRPH

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Consumer goods

Industry

Household/personal hygiene

Overview Dividends Analysts Charts News Strategies

ProPhase Labs, Inc. Target price 2025 - Analyst rating & recommendation

ProPhase Labs, Inc. Classifications & Recommendation:

Buy

100%

ProPhase Labs, Inc. Price Target

Target Price	$16.00
Price	$0.35
Potential	4,524.28% register free of charge
Number of Estimates	1

	1 Analyst has issued a ProPhase Labs, Inc. price target 2026. The average ProPhase Labs, Inc. target price is $16.00. This is 4,524.28% register free of charge higher than the current stock price.
	A rating was issued by 1 analysts: 1 Analysts recommend ProPhase Labs, Inc. to buy, 0 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the ProPhase Labs, Inc. stock has an average upside potential 2026 of 4,524.28% register free of charge . Most analysts recommend the ProPhase Labs, Inc. stock at Purchase.

Sales and Margin forecast 2025, 2026 & 2027

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually

	Dec '24	2025 Estimates
Revenue Million $	6.77	21.36
	80.65%	215.47%

1 Analyst has issued a sales forecast ProPhase Labs, Inc. 2025 . The average ProPhase Labs, Inc. sales estimate is

Unlock

. This is

Unlock

than the revenue of the last 12 months(TTM). The highest sales forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics:

2024	$6.8m	80.65%
2025	$21.4m 215.47% Unlock
2026	$41.7m 95.20% Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027

Create a premium account to unlock analyst estimates. Learn more

Annually

	Dec '24	2025 Estimates
EV/Sales		1.82

Based on analysts' sales estimates for 2025, the ProPhase Labs, Inc. stock is valued at an EV/Sales of

Unlock

and an P/S ratio of

Unlock

This results in the following potential growth metrics and future valuations:

Current	3.05	2.01%
2025	1.82 40.39% Unlock
2026	0.93 48.77% Unlock

Current	0.81	69.17%
2025	0.48 40.31% Unlock
2026	0.25 48.77% Unlock

ProPhase Labs, Inc....

Discover more stocks with a high price target

Novo Nordisk 83.92%

Coinbase Global, Inc. 83.53%

BioNTech SE - ADR 50.09%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now